SCHEMBL901983

SCHEMBL901983

CCCCCCC[n+]1ccccc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 4/20 1.00
CHRM2 P08172 2/20 1.00
ADRA2A P08913 2/20 1.00
ADORA3 P0DMS8 2/20 1.00
CHRM1 P11229 2/20 1.00
SLC6A2 P23975 2/20 1.00
SLC6A4 P31645 2/20 1.00
SLC6A3 Q01959 2/20 1.00
ABCB11 O95342 1/20 1.00
ESR1 P03372 1/20 1.00
PGR P06401 1/20 1.00
HTR1A P08908 1/20 1.00
DRD1 P21728 1/20 1.00
TBXA2R P21731 1/20 1.00
PTGS1 P23219 1/20 1.00
PDE4A P27815 1/20 1.00
ADRA1A P35348 1/20 1.00
OPRM1 P35372 1/20 1.00
DRD3 P35462 1/20 1.00
KCNH2 Q12809 1/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8383492 1.00 ACHE (1.00) ACHECHRM2ADRA2AADORA3CHRM1
Heptane SCHEMBL9741951 1.00 ACHE (1.00) ACHECHRM2ADRA2AADORA3CHRM1
SCHEMBL5289483 1.00 ACHE (1.00) ACHECHRM2ADRA2AADORA3CHRM1
SCHEMBL5295618 1.00 ACHE (1.00) ACHECHRM2ADRA2AADORA3CHRM1
SCHEMBL628712 1.00 ACHE (1.00) ACHECHRM2ADRA2AADORA3CHRM1
SCHEMBL8382949 1.00 ACHE (1.00) ACHECHRM2ADRA2AADORA3CHRM1
SCHEMBL902721 1.00 ACHE (1.00) ACHECHRM2ADRA2AADORA3CHRM1
SCHEMBL5291462 1.00 ACHE (1.00) ACHECHRM2ADRA2AADORA3CHRM1
SCHEMBL5291225 1.00 ACHE (1.00) ACHECHRM2ADRA2AADORA3CHRM1
SCHEMBL8385052 1.00 ACHE (1.00) ACHECHRM2ADRA2AADORA3CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 150 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025128828-A1 METHODS OF SOLVENT DISPLACEMENT FOR METAL-CONTAINING IONIC LIQUIDS CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2025-06-19 WO claimed
US-20250196021-A1 METHODS OF SOLVENT DISPLACEMENT FOR METAL-CONTAINING IONIC LIQUIDS CHEVRON PHILLIPS CHEMICAL COMPANY LP 2025-06-19 US claimed
CN-114814013-B Method for rapidly screening unknown chemical hazard residues in aquatic products based on high-resolution mass spectrum database 中国海洋大学 2023-06-02 CN claimed
CN-116148398-A Method for detecting trace chemical hazard in fat-rich food 北京市疾病预防控制中心 2023-05-23 CN claimed
CN-107427758-B Separation using ionic liquid solvents 切弗朗菲利浦化学公司 2020-11-20 CN claimed
US-10227274-B2 Separations with ionic liquid solvents CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2019-03-12 US claimed
CN-107427758-A Utilize the separation of ion liquid solvent 切弗朗菲利浦化学公司 2017-12-01 CN claimed
EP-3244987-A1 SEPARATIONS WITH IONIC LIQUID SOLVENTS Chevron Phillips Chemical Company LP (US) 2017-11-22 EP claimed
US-20150133711-A1 Separations With Ionic Liquid Solvents CHEVRON PHILLIPS CHEMICAL COMPANY LP 2015-05-14 US claimed
US-20260121095-A1 Advanced Ion Exchange Membranes And Applications Thereof WILLIAMS RICHARD KENT (US) 2026-04-30 US disclosed
US-20260015304-A1 METAL-CONTAINING IONIC LIQUIDS WITH REDUCED VISCOSITY CHEVRON PHILLIPS CHEMICAL CO LP (US) 2026-01-15 US disclosed
US-12441671-B2 Metal-containing ionic liquids with reduced viscosity CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2025-10-14 US disclosed
US-12365647-B2 Method for preparing acrylonitrile dimer LG CHEM, LTD. (KR) 2025-07-22 US disclosed
US-20250196021-A1 METHODS OF SOLVENT DISPLACEMENT FOR METAL-CONTAINING IONIC LIQUIDS CHEVRON PHILLIPS CHEMICAL COMPANY LP 2025-06-19 US disclosed
WO-2005105815-A1 IONIC LIQUIDS COMPRISING FLUORALKYLTRIFFLUOROBORATE ANIONS MERCK PATENT GMBH (DE) 2005-11-10 WO disclosed
US-6816298-B2 CAN BE PRODUCED WITH INEXPENSIVE CHROMOGENIC MATERIALS; DISPLAY DEVICES, SMART WINDOWS, ANTIGLARE MIRRORS FOR AUTOMOBILES, ELECTROCHROMIC MIRRORS; A BIPYRIDINIUM METALLOCENE COMPOUND IN THE ION CONDUCTIVE LAYER NIPPON MITSUBISHI OIL CORPORATION (JP) 2004-11-09 US disclosed
US-20030184839-A1 Electrochromic device NIPPON MITSUBISHI OIL CORPORATION 2003-10-02 US disclosed
US-6519072-B2 Electrochromic device NIPPON MITSUBISHI OIL CORPORATION (JP) 2003-02-11 US disclosed
US-20020015214-A1 Electrochromic Device NIPPON MITSUBISHI OIL CORPORATION 2002-02-07 US disclosed
EP-1154311-A1 ELECTROCHROMIC ELEMENT Nippon Mitsubishi Oil Corporation (JP) 2001-11-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260121095-A1 Advanced Ion Exchange Membranes And Applications Thereof MYOC, MB, MYOF ACHE 1427/4885CHRM2 433/4885ADRA2A 4412/4885
US-12365647-B2 Method for preparing acrylonitrile dimer ADH1C, ADH1A, PUF60 ACHE 3675/4885CHRM2 2570/4885ADRA2A 3466/4885
US-20260015304-A1 METAL-CONTAINING IONIC LIQUIDS WITH REDUCED VISCOSITY EXOC3, ELL, IGF2BP2 ACHE 1269/4885CHRM2 991/4885ADRA2A 4693/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.